New lipid management guidelines published
Lipid management guidelines for adults with diabetic nephropathy or chronic kidney disease (CKD) have been published in a prestigious diabetes journal.
A summarised version of the document, which was jointly developed by the Association of British Clinical Diabetologists (ABCD) and the Renal Association, has been included in the latest edition of the British Journal of Diabetes.
The organisations decided to focus on lipids because they were a “modifiable risk factor” which if managed well can offer “improved outcomes for diabetic patients with concomitant renal disease”.
Having studied the available research and current medical advice, the authors have published 28 suggested guidelines for how healthcare professionals approach lipid management guidelines in adults with diabetic nephropathy or chronic kidney disease (CKD).
The clinical practice guidelines were based upon systematic literature searches conducted between October 2013 and March 2016. PubMed and MEDLINE were used, along with the Cochrane database of systematic reviews and hand-searched reference lists and articles were identified by the writing group members up till March 2016.
All related guidelines from the National Institute for health and Clinical Excellence (NICE), the Renal Association, Kidney Disease Improving Global outcomes (KDIGO), the European Renal Association Best Practice Guidelines and the American and European Diabetes Associations were also reviewed.
The authors stated that several guidelines, published in the past two years, do not specifically refer to the management of lipids in diabetes nephropathy and at different stages of CKD.
Some of the issues covered within the document include looking at the safety profile of high intensity safety and efficacy of lipid lowering therapies, statin side effects and safety in CKD and research which has looked at the CVD risk in people with diabetes who require dialysis.
To read the guidelines in full, click here.